Concepedia

Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy

Sheila M. Hegde, Steven J. Lester, Scott D. Solomon, Michelle Michels, Perry Elliott, Sherif F. Nagueh, Lubna Choudhury, David Zemánek, Donna R. Zwas, Daniel Jacoby,

Journal of the American College of Cardiology · 2021 · 191 citations · 31 references

DOIFull text

Open access

Concepts

References

31

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Roberto M. Lang, Luigi P. Badano, Victor Mor‐Avi et al. · Journal of the American Society of Echocardiography · 2015 · 18K citations · Full text

, , +17

Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Sherif F. Nagueh, Otto A. Smiseth, Christopher P. Appleton et al. · Journal of the American Society of Echocardiography · 2016 · 6.7K citations · Full text

, , +14

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

Stefano Nistri · European Heart Journal · 2014 · 4.3K citations · Full text

, , +13

Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy

Martin S. Maron, Iacopo Olivotto, Sandro Betocchi et al. · New England Journal of Medicine · 2003 · 1.5K citations · Full text

, , +4

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.2K citations · Full text

, , +6